Molecular Basis of Bone Abnormalities in NF1

[1]  I. Alexander,et al.  A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast‐like cells , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Jeffrey E. Swensen,et al.  Bone resorption in syndromes of the Ras/MAPK pathway , 2011, Clinical genetics.

[3]  J. Nyman,et al.  Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I. , 2011, Human molecular genetics.

[4]  A. Robling,et al.  The Haploinsufficient Hematopoietic Microenvironment Is Critical to the Pathological Fracture Repair in Murine Models of Neurofibromatosis Type 1 , 2011, PloS one.

[5]  A. Ruys,et al.  Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate. , 2011, The Journal of bone and joint surgery. British volume.

[6]  Yingze Zhang,et al.  Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model. , 2011, Bone.

[7]  D. Stevenson,et al.  The musculoskeletal phenotype of the RASopathies , 2011, American journal of medical genetics. Part C, Seminars in medical genetics.

[8]  J. Carey,et al.  Multiple increased osteoclast functions in individuals with neurofibromatosis type 1 , 2011, American journal of medical genetics. Part A.

[9]  P. Robinson,et al.  Neurofibromin (Nf1) is required for skeletal muscle development. , 2011, Human molecular genetics.

[10]  T. Kuorilehto,et al.  Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation. , 2010, Bone.

[11]  J. Nyman,et al.  Local Low-Dose Lovastatin Delivery Improves the Bone-Healing Defect Caused by Nf1 Loss of Function in Osteoblasts , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  R. Nuti,et al.  Quantitative ultrasound and dual-energy x-ray absorptiometry in children and adolescents with neurofibromatosis of type 1. , 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[13]  B. MacWilliams,et al.  Motor Proficiency in Children With Neurofibromatosis Type 1 , 2010, Pediatric physical therapy : the official publication of the Section on Pediatrics of the American Physical Therapy Association.

[14]  S. Mundlos,et al.  Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options , 2009, American journal of medical genetics. Part A.

[15]  J. Carey,et al.  Tibial geometry in individuals with neurofibromatosis type 1 without anterolateral bowing of the lower leg using peripheral quantitative computed tomography. , 2009, Bone.

[16]  R. Friedrich,et al.  High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1 , 2009, Osteoporosis International.

[17]  L. Rodrigues,et al.  Muscular force is reduced in neurofibromatosis type 1. , 2009, Journal of musculoskeletal & neuronal interactions.

[18]  R. Friedrich,et al.  Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1) , 2008, Journal of Medical Genetics.

[19]  C. Chung,et al.  Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1. , 2008, The Journal of bone and joint surgery. American volume.

[20]  D. Turkkahraman,et al.  Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1 , 2008, Brain and Development.

[21]  M. McDonald,et al.  Models of tibial fracture healing in normal and Nf1‐deficient mice , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  S. Mundlos,et al.  Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin , 2008, BMC medicine.

[23]  A. Robling,et al.  Erratum: Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1 (Human Molecular Genetics (2008) vol. 17(7) (936-948) 10.1093/hmg/ddm366) , 2008 .

[24]  J. Carey,et al.  Evidence of Increased Bone Resorption in Neurofibromatosis Type 1 Using Urinary Pyridinium Crosslink Analysis , 2008, Pediatric Research.

[25]  Alyssa A. Tran,et al.  Generalized metabolic bone disease in Neurofibromatosis type I. , 2008, Molecular genetics and metabolism.

[26]  M. McDonald,et al.  Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild‐type and Nf1 haploinsufficient mice , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[27]  A. Robling,et al.  Rac1 mediates the osteoclast gains-in-function induced by haploinsufficiency of Nf1. , 2007, Human molecular genetics.

[28]  N. Eskiyurt,et al.  Bone mineral density in children with neurofibromatosis 1 , 2007, Acta paediatrica.

[29]  Tatsuya Yoshida,et al.  Congenital pseudarthrosis of the tibia: analysis of the histology and the NF1 gene , 2007, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[30]  A. Crawford,et al.  The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1 , 2007, Genetics in Medicine.

[31]  C. Cowell,et al.  Decreased Bone Mineral Density in Neurofibromatosis Type 1: Results From a Pediatric Cohort , 2007, Journal of pediatric orthopedics.

[32]  S. Mundlos,et al.  Multiple roles for neurofibromin in skeletal development and growth. , 2007, Human molecular genetics.

[33]  J. Carey,et al.  Bone mineral density in children and adolescents with neurofibromatosis type 1. , 2007, The Journal of pediatrics.

[34]  D. Ron,et al.  ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. , 2006, Cell metabolism.

[35]  A. Robling,et al.  Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. , 2006, The Journal of clinical investigation.

[36]  Menggang Yu,et al.  Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. , 2006, Human molecular genetics.

[37]  J. Carey,et al.  Double inactivation of NF1 in tibial pseudarthrosis. , 2006, American journal of human genetics.

[38]  S. Störkel,et al.  Decreased bone mineral density in patients with neurofibromatosis 1 , 2005, Osteoporosis International.

[39]  J. Carey,et al.  Case-control study of the muscular compartments and osseous strength in neurofibromatosis type 1 using peripheral quantitative computed tomography. , 2005, Journal of musculoskeletal & neuronal interactions.

[40]  J. Friedman,et al.  Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? , 2005, Clinical genetics.

[41]  E. Everett,et al.  Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. , 2005, Bone.

[42]  P. Barros-Núñez,et al.  Hamartoma Involving the Pseudarthrosis Site in Patients With Neurofibromatosis Type 1 , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[43]  R. Bloigu,et al.  Decreased bone mineral density and content in neurofibromatosis type 1: Lowest local values are located in the load-carrying parts of the body , 2005, Osteoporosis International.

[44]  J. Koivunen,et al.  NF1 Tumor Suppressor Protein and mRNA in Skeletal Tissues of Developing and Adult Normal Mouse and NF1‐Deficient Embryos , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[45]  M. Blauth,et al.  Light- and electron-microscopic studies in congenital pseudarthrosis , 2004, Archives of orthopaedic and traumatic surgery.

[46]  D. Skaggs,et al.  Orthopaedic manifestations of neurofibromatosis in children: an update. , 2002, Clinical orthopaedics and related research.

[47]  K. North,et al.  Review Article : Neurofibromatosis 1: Clinical Review and Exceptions to the Rules , 2002, Journal of child neurology.

[48]  G. Karsenty,et al.  Mouse α1(I)‐collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast , 2002, Developmental dynamics : an official publication of the American Association of Anatomists.

[49]  J. Marth,et al.  Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. , 2001, Genes & development.

[50]  J. Dubousset,et al.  Decreased Bone Mineral Density in Neurofibromatosis-1 Patients with Spinal Deformities , 2001, Osteoporosis International.

[51]  A. Crawford,et al.  Modulation of Spinal Deformities in Patients With Neurofibromatosis Type 1 , 2000, Spine.

[52]  S. Wientroub,et al.  Pathology of Bone Lesions Associated With Congenital Pseudarthrosis of the Leg , 2000, Journal of pediatric orthopedics. Part B.

[53]  A. Crawford,et al.  Neurofibromatosis in children: the role of the orthopaedist. , 1999, The Journal of the American Academy of Orthopaedic Surgeons.

[54]  R. Tenconi,et al.  Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. , 1999, American journal of medical genetics.

[55]  M. Ruggieri,et al.  Congenital bone malformations in patients with neurofibromatosis type 1 (Nf1). , 1999, Journal of pediatric orthopedics.

[56]  J A Epstein,et al.  Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. , 1998, Development.

[57]  B. Korf,et al.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, JAMA.

[58]  J. Friedman,et al.  Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. , 1997, American journal of medical genetics.

[59]  N. Copeland,et al.  Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. , 1994, Genes & development.

[60]  E. Yunis,et al.  Ultrastructure of congenital pseudarthrosis of the tibia. , 1973, Archives of pathology.